# Severe Chronic Respiratory Failure and Citrulline

> **NCT03694964** · NA · UNKNOWN · sponsor: **University Hospital, Grenoble** · enrollment: 60 (estimated)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** ProteoCIT®
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03694964
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01
- **Primary completion:** 2019-01
- **Final completion:** 2021-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03694964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03694964, "Severe Chronic Respiratory Failure and Citrulline". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT03694964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*